It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2012.
2012 | Hyderabad, Telangana, India | AmalgamatedElite Pharmaceutical Private Limited, a amalgamated private limited company, was established on 29 March 2012 in Hyderabad, Telangana, India. Engaging in pharma contract r&d within the pharma sector, it holds CIN: U24232TG2012PTC080006. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹1.50 M.
It upholds a compliant status. Its leadership includes Mounika Ganapuram (Director), Pallavi Lakki Reddy (Director). Past directors included Mounika Ganapuram, Thirupathi Reddy Lakkireddy, Venugopal Reddy Gopu. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at 1-48/3/2 Shanker Nagar Chandanagar, Hyderabad, Telangana, 502050.
U24232TG2012PTC080006
080006
29 March 2012
₹5.00 M
₹1.50 M
Roc Hyderabad
Unlisted
Amalgamated
Explore comprehensive insights into Elite Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mounika Ganapuram | Director | 08 Mar 2017 | Current |
| Pallavi Lakki Reddy | Director | 29 Mar 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2017 | Past |
| Pramod Abcsdd | Director | 03 Oct 2022 | Past |
| Pramod Abcsdd | Additional Director | 15 Jun 2019 | Past |
| Pramod Abcsdd | Director | 09 Nov 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Elite Pharmaceutical Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2015, Elite Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Elite Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Elite Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elite Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Elite Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was documented.
The activity Elite Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Hyderabad. was completed.
Progress on Mounika Ganapuram was appointed as a Director was appointed as a Director on 08 Mar 2017 & has been associated with this company since 8 years 9 months . was documented.
The activity Pallavi Lakki Reddy was appointed as a Director was appointed as a Director on 29 Mar 2012 & has been associated with this company since 13 years 8 months . was completed.
Progress on Elite Pharmaceutical Private Limited was registered on 29 Mar 2012 with Roc Hyderabad & aged 13 years 8 months as per MCA records. was documented.
The CIN of Elite Pharmaceutical Private Limited is U24232TG2012PTC080006.
Elite Pharmaceutical Private Limited is headquartered at 1-48/3/2 Shanker Nagar Chandanagar, Hyderabad, Telangana, 502050.
Elite Pharmaceutical Private Limited was incorporated on 29 March 2012.
The current directors of Elite Pharmaceutical Private Limited are
The primary industry of Elite Pharmaceutical Private Limited is Pharma.
Elite Pharmaceutical Private Limited is unlisted.
The authorized capital of Elite Pharmaceutical Private Limited is ₹5.00 M, and the paid-up capital is ₹1.50 M.
The compliance status of Elite Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX